AWM
ALXA

Avior Wealth Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Avior Wealth Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-765
Closed -$3K – 355
2014
Q1 		$3K Buy
+765
New +$3.92K ﹤0.01% 307

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Avior Wealth Management's ALXA Position: Q2 2014 in Review

Avior Wealth Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2014, closing a stake of 765 shares — an estimated $3K sold.

Avior Wealth Management first reported a position in ALXA in Q1 2014 and held it in 1 quarter. The position peaked at $3K in Q1 2014. 40 funds tracked by Wall St. Rank hold ALXA as of Q2 2014.

  • Avior Wealth Management reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Avior Wealth Management sold 765 Alexza Pharmaceuticals Inc shares in Q2 2014, an estimated $3K.
  • Avior Wealth Management first reported a position in Alexza Pharmaceuticals Inc in Q1 2014 and held it in 1 quarter.
  • Avior Wealth Management's Alexza Pharmaceuticals Inc position peaked at $3K in Q1 2014.
  • 40 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2014.

Based on Avior Wealth Management's 13F filing for Q2 2014, filed 14 Aug 2014.